Talk:Ibrutinib

Can we reduce width on chembox on right

Currently (at least for me in Firefox) it looks about 40 chars wide and would be better at about half the current width. Can't see what sets the display width. - Rod57 (talk) 23:45, 9 April 2013 (UTC)

OK now. - Rod57 (talk) 14:15, 20 November 2016 (UTC)

Why no mention of atrial fibrillation as adverse effect

atrial fibrillation not mentioned in Adverse effects - despite efforts to treat IRAF eg [1], and that review saying different studies reported 5, 6 or 7% incidence of AF with ibrutinib use. - Rod57 (talk) 14:34, 20 November 2016 (UTC)

old refs. updated them, and content based on them. Jytdog (talk) 21:27, 20 November 2016 (UTC)

Bleeding

Is common doi:10.1111/jth.13651 JFW | T@lk 21:28, 2 May 2017 (UTC)

So common that this is the second review in a short period! doi:10.1182/bloodadvances.2016001883 JFW | T@lk 20:38, 9 May 2017 (UTC)

New text

"Ibrutinib is now the preferred first-line treatment for most patients with CLL"

One of the issue with this paper is that some of the authors are being paid by AbbVie.[2]

Add to that that the authors appear to be trying to add it themselves.

Table 2 lists a number of first line treatments. Doc James (talk · contribs · email) 18:27, 17 February 2019 (UTC)

Found a better ref, NCI. https://www.cancer.gov/types/leukemia/hp/cll-treatment-pdq Doc James (talk · contribs · email) 00:38, 19 February 2019 (UTC)

US cost of Imbruvica -- reference, and add to Economic section

Treatment cost of Imbruvica $160,000 per year cited in Congressional hearing by Rep Ro Khanna of California on 10 Feb 2024. https://twitter.com/perry_ron/status/1756319357179953277 217.155.151.38 (talk) 12:40, 11 February 2024 (UTC)